MCOM IP, LLC v. City National Bank of Florida

District Court, S.D. Florida·Decided June 7, 2024·No. 1:23-cv-23427·Unknown

Opinion

United States District Court for the Southern District of Florida

mCom IP, LLC, Plaintiff, ) ) v. ) Civil Action No. 23-23427-Civ-Scola ) City National Bank of Florida, ) Defendant. ) Order Granting Motion to Dismiss This matter is before the Court on Defendant City National Bank of Florida’s motion to dismiss the amended complaint. (ECF No. 30.) The Plaintiff has responded (ECF No. 32), and the Defendant has filed a reply (ECF No. 33). The Court has considered the briefing, the record, the relevant legal authorities, and is otherwise fully advised. The Court grants the Defendant’s motion to dismiss for the reasons discussed below. (ECF No. 30.) 1. Background This case concerns the Defendant, City National Bank of Florida, allegedly infringing a patent relating to what the Plaintiff claims are “novel and improved systems and methods for constructing a unified banking system.” (Am. Compl., ECF No. 26 ¶ 9.) City National is a bank based in Coral Gables, Florida, and the Plaintiff, mCom IP, LLC is a Texas limited liability company that owns the relevant patent by assignment. (Id. ¶¶ 1-2, 6.) On October 14, 2014, the U.S. Patent and Trademark Office issued U.S. Patent No. 8,862,508 (the “’508 Patent”), entitled “System and method for unifying e-banking touch points and providing personalized financial services.” (Id. ¶ 6.) The ‘508 Patent’s abstract describes it as a “system and method for delivering a retail banking multi-channel solution that unifies interactive electronic banking touch points to provide personalized financial services to customers and a common point of control for financial institutions . . . .” (‘508 Patent, ECF No. 26-1 at 2.) For purposes of the motion to dismiss, the Court accepts the facts in the amended complaint as true and construes them in the light most favorable to the Plaintiff. See Pielage v. McConnell, 516 F.3d 1282, 1284 (11th Cir. 2008). The amended complaint alleges that the Defendant has infringed claims 2, 8, 14, and 17 of the ‘508 Patent. (Am. Compl. ¶ 10.) The Plaintiff attaches a claim chart that aims to provide support for its allegations that City National “maintains, operates, and administers systems, products, and services of unified banking systems that infringes one or more of claims of the ‘508 patent, including one or more of claims 2, 8, 14, and 17,” which consists of screenshots of City National’s website accompanied by text from the ‘508 Patent. (Id. ¶ 10.) According to the amended complaint, City National has also induced infringement of and contributorily infringed the ‘508 Patent by “actively encourage[ing] or instruct[ing] others (e.g., its customers and/or the customers of its related companies), and continues to do so, on how to construct a unified banking system of one or more of claims 2, 7, 14, and 17 of the ‘508 patent . . . .” (Id. ¶ 12.) On February 8, 2023, the Patent Trial and Appeal Board (“PTAB”) issued a final written decision in a separate proceeding challenging the patentability of claims 1, 3-7, 9-13, 15, 16, and 18-20 of the ‘508 Patent. Unified Patents, LLC v. mCom IP, LLC, IPR2022-00055, Final Written Decision (PTAB Feb. 8, 2023).1 The PTAB concluded that claims 1, 3-7, 9-13, 15, 16, and 18-20 are obvious and therefore unpatentable. Id. at 38-40. mCom failed to appeal the decision, and those claims were canceled. “[W]hen a claim is cancelled, the patentee loses any cause of action based on that claim, and any pending litigation in which the claims are asserted becomes moot.” Sanofi-Aventis U.S., LLC v. Dr. Reddy’s Laboratories, Inc., 933 F.3d 1367, 1373 (Fed. Cir. 2019) (citing Fresenius USA, Inc. v. Baxeter Int’l, Inc., 721 F.3d 1330, 1340 (Fed. Cir. 2013)). The patent’s remaining claims, which went unchallenged in the PTAB proceedings, are at issue here. The Court previously struck the Plaintiff’s complaint on the grounds that the complaint constituted an impermissible shotgun pleading. (ECF No. 25.) The Plaintiff then filed the amended complaint. (ECF No. 26.) City National now argues that the amended complaint should be dismissed because it remains a shotgun pleading, fails to state a claim for either direct or indirect patent infringement, and because the Plaintiff has not alleged patentable subject matter. (ECF No. 30.) 2. Legal Standard A court considering a motion to dismiss, filed under Federal Rule of Civil Procedure 12(b)(6), must accept all of the complaint's allegations as true, construing them in the light most favorable to the plaintiff. Pielage v. McConnell, 516 F.3d 1282, 1284 (11th Cir. 2008). Although a pleading need only contain a short and plain statement of the claim showing that the pleader is entitled to relief, a plaintiff must nevertheless articulate “enough facts to

1 The Court can take judicial notice of PTAB documents. Viskase Corp. v. Am. Nat. Can Co., 261 F.3d 1316, 1328 n.2 (Fed. Cir. 2001). state a claim to relief that is plausible on its face.” Bell Atl. Corp. v. Twombly, 550 U.S. 544, 570 (2007). “But where the well-pleaded facts do not permit the court to infer more than the mere possibility of misconduct, the complaint has alleged—but it has not shown—that the pleader is entitled to relief.” Ashcroft v. Iqbal, 556 U.S. 662, 679 (2009) (quoting Fed. R. Civ. P. 8(a)(2)) (cleaned up). A court must dismiss a plaintiff’s claims if she fails to nudge her “claims across the line from conceivable to plausible.” Twombly, 550 U.S. at 570. 3. Analysis City National argues that mCom has failed to plead infringement because claims 2, 8, 14, and 17 of the ‘508 Patent depend upon claims that the PTAB has already canceled for obviousness, and regardless, that the pleadings are devoid of factual support connecting City National to the alleged patented technology. Furthermore, according to the Defendant, even if the ‘508 Patent’s claims were patentable, the amended complaint still constitutes an impermissible shotgun pleading because it comingles claims for direct and indirect (contributory and induced) patent infringement into one single count generally titled “INFRINGEMENT.” (Mot. at 8-9.) The Court agrees with City National that the amended complaint does not comply with pleading standards and fails to distinguish claims 2, 8, 14, and 17 from the invalid patent claims that canceled by the PTAB. The Court considers each asserted claim in turn. A. Claims 2 and 8 City National argues that the infringement claims relating to claims 2 and 8 must be dismissed because they depend upon canceled claims 1 and 7, respectively, and do not add patentable subject matter to those claims. City National also argues that neither the amended complaint nor the claims chart make factual allegations tying any method practiced by the Defendant to any element of claims 2 (including underlying claim 1) or 8 (including underlying claim 7). (Mot. at 10-11.) City National is correct on both fronts, and as a threshold matter, the Court may consider the validity of the ‘508 Patent’s claims at the motion to dismiss stage. See Ultramercial, Inc. v. Hulu, LLC, 772 F.3d 709, 719 (Fed. Cir.

Free access — add to your briefcase to read the full text and ask questions with AI

MCOM IP, LLC v. City National Bank of Florida, (S.D. Fla. 2024).

MCOM IP, LLC v. City National Bank of Florida (MCOM IP, LLC v. City National Bank of Florida) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Pielage v. McConnell
516 F.3d 1282 (Eleventh Circuit, 2008)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Viskase Corporation v. American National Can Company
261 F.3d 1316 (Federal Circuit, 2001)
Fresenius USA, Inc. v. Baxter International, Inc.
721 F.3d 1330 (Federal Circuit, 2013)
Ultramercial, Inc. v. Hulu, LLC
772 F.3d 709 (Federal Circuit, 2014)
Cita Trust Company AG v. Fifth Third Bank
879 F.3d 1151 (Eleventh Circuit, 2018)
Sanofi-Aventis U.S., LLC v. Fresenius Kabi USA, LLC
933 F.3d 1367 (Federal Circuit, 2019)